You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

personalized tumor vaccines

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023

Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Pancreatic Cancer
  • Personalized neoantigen tumor vaccine
  • Qionghai, Hainan, China
    Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023

Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)

Not yet recruiting
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Pancreatic Cancer Trial in United States (Atezolizumab, RO7198457, mFOLFIRINOX)

Active, not recruiting
  • Pancreatic Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jan 12, 2022

Pancreatic Tumor Trial in Shanghai (Personalized neoantigen vaccine)

Recruiting
  • Pancreatic Tumor
  • Personalized neoantigen vaccine
  • Shanghai, Shanghai, China
    Changhai Hospital
Mar 8, 2022

Tumor Vaccines for Solid Tumors

Recruiting
  • Glioma
  • Solid Tumor
  • tumor vaccine
  • +3 more
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Oct 22, 2023

Tumors Trial in Tijuana (Neoantigen Peptides)

Recruiting
  • Neoplasms
  • Neoantigen Peptides
  • Tijuana, Baja California, Mexico
    Instituto de Medicina Regenerativa
Jul 22, 2022

Circulating Tumor DNA in Pancreatic Cancer UsingPersonalized

Recruiting
  • Pancreatic Cancer
  • No intervention
  • Kashiwa, Japan
    National Cancer Center Hospital East
Sep 12, 2023

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Solid Tumor Trial in Beijing (Personalized neoantigen tumor vaccine)

Not yet recruiting
  • Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 28, 2022

Recurrent or Metastatic Bladder Cancer Trial in Shanghai (Chimeric exosomal tumor vaccines)

Recruiting
  • Recurrent or Metastatic Bladder Cancer
  • Chimeric exosomal tumor vaccines
  • Shanghai, China
    Fudan University Pudong Medical Center
Sep 26, 2022

NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose

Recruiting
  • Non-small Cell Lung Cancer
  • Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
  • Low dose cyclophosphamide
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jan 17, 2022

GBM, Glioma Glioblastoma Multiforme, Tumor, Brain Trial (Whole Brain Spectroscopy Imaging Array Mapping Layout)

Recruiting
  • GBM
  • +2 more
  • Whole Brain Spectroscopy Imaging Array Mapping Layout
  • Philadelphia, Pennsylvania
  • +1 more
Jan 19, 2023

Prostate Cancer Trial in New York (PGV-001, Poly-ICLC, CDX-301)

Recruiting
  • Prostate Cancer
  • PGV-001
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai (ISMMS)
Aug 10, 2021

Personalized Home Exercise Program in Bone Tumor Undergoing

Recruiting
  • Osteosarcoma
  • +3 more
    • Bologna, Italy
      Istituto Ortopedico Rizzoli
    Mar 21, 2023

    Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

    Not yet recruiting
    • Posto Perative Hepatocellular Carcinoma
    • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
    • (no location specified)
    Feb 27, 2023

    Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)

    Terminated
    • Neuroblastoma
    • Cancer
    • Biopsy
    • +12 more
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Jan 31, 2023

    s Recurrence and Response Via a Tumor Informed Assessment

    Recruiting
    • Cancer
    • +4 more
    • Personalized Cancer Monitoring (PCM)
    • San Francisco, California
    • +1 more
    Dec 5, 2022

    Advanced Malignant Solid Tumor Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

    Active, not recruiting
    • Advanced Malignant Solid Tumor
    • iNeo-Vac-P01
    • GM-CSF
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital
    Nov 15, 2021

    Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in

    Recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 26, 2022

    Solid Tumor Trial in Copenhagen (Tumor biopsy)

    Recruiting
    • Unspecified Adult Solid Tumor, Protocol Specific
    • Tumor biopsy
    • Copenhagen, Denmark
      Rigshospitalet
    Oct 25, 2022

    Follicular Lymphoma Trial in Saint Louis (biological, drug, procedure)

    Suspended
    • Follicular Lymphoma
    • Personalized tumor vaccine
    • +6 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 9, 2021

    Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

    Not yet recruiting
    • Advanced Malignant Solid Tumors
    • Neoantigen peptide vaccine
    • Neoantigen-based DC immune preparation
    • Nanchang, Jiangxi, China
      First Affiliated Hospital of Nanchang University
    Mar 1, 2023